Quest Diagnostics (DGX) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US74834L1008

Blood tests, Clinical testing, Anatomic pathology, Diagnostic services

Quest Diagnostics Incorporated is a leading provider of diagnostic testing and services, operating in the United States and internationally. The company offers a comprehensive range of diagnostic information services, including routine, non-routine, and advanced clinical testing, as well as anatomic pathology testing.

Through its network of laboratories, patient service centers, and mobile phlebotomists, Quest Diagnostics provides diagnostic information services to a diverse range of clients, including physicians, hospitals, patients, and consumers, as well as health plans, government agencies, employers, retailers, pharmaceutical companies, and insurers. The company's services are offered under various brands, including Quest Diagnostics, AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.

In addition to its diagnostic testing services, Quest Diagnostics also provides risk assessment services for the life insurance industry. Furthermore, the company offers healthcare organizations and clinicians information technology solutions to help them make informed decisions and improve patient care.

With a rich history dating back to 1967, Quest Diagnostics Incorporated is headquartered in Secaucus, New Jersey, and has established itself as a trusted partner for healthcare providers, patients, and other stakeholders in the healthcare ecosystem. The company's commitment to innovation, quality, and customer service has enabled it to maintain its position as a leader in the diagnostic testing industry.

For more information about Quest Diagnostics Incorporated, please visit their website at

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Quest Diagnostics (DGX) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Quest Diagnostics (DGX) - Stock Price & Dividends

DGX Stock Overview

Market Cap in USD 15,772m
Sector Healthcare
Industry Diagnostics & Research
GiC SubIndustry Health Care Services
TER 0.00%
IPO / Inception 1996-12-17

DGX Stock Ratings

Growth 5y 39.7
Fundamental 30.8
Dividend 7.22
Rel. Performance vs Sector -0.96
Analysts 3.59/5
Fair Price Momentum 132.85 USD
Fair Price DCF 233.64 USD

DGX Dividends

Yield 12m 2.07%
Yield on Cost 5y 3.17%
Dividends CAGR 5y 5.65%
Payout Consistency 98.7%

DGX Growth Ratios

Growth 12m 0.39%
Growth Correlation 12m 14%
Growth Correlation 3m 53%
CAGR 5y 8.88%
CAGR/Mean DD 5y 0.74
Sharpe Ratio 12m -0.25
Alpha vs SP500 12m -17.51
Beta vs SP500 5y weekly 0.57
ValueRay RSI 41.93
Volatility GJR Garch 1y 18.28%
Price / SMA 50 0.99%
Price / SMA 200 6.05%
Current Volume 908.5k
Average Volume 20d 830.7k

External Links for DGX Stock

Wall Street JournalBenzingaYahoo Finance
Fund Manager Positions
What is the price of DGX stocks?
As of June 22, 2024, the stock is trading at USD 138.96 with a total of 908,537 shares traded.
Over the past week, the price has changed by +0.81%, over one month by -3.06%, over three months by +8.48% and over the past year by +2.44%.
What are the forecast for DGX stock price target?
According to ValueRays Forecast Model, DGX Quest Diagnostics will be worth about 144.7 in June 2025. The stock is currently trading at 138.96. This means that the stock has a potential upside of +4.09%.
Issuer Forecast Upside
Wallstreet Target Price 147.1 5.84
Analysts Target Price 146.3 5.29
ValueRay Target Price 144.7 4.09